Top of this page
Skip navigation, go straight to the content

Research & Development

UCB's goal is to command a leading position in discovering and developing new therapies to treat patients suffering from severe diseases. With a strong pipeline, our focus is on neurology and immunology, where we aim to provide new treatments for specialists and their patients.

Our key features

  • Patients are at the heart of all we do, driving our commitment to the treatment of severe diseases
  • A focus on two therapeutic areas: neurology and immunology
  • An attractive late stage pipeline
  • An international R&D organization comprised of UCB New Medicines™ and UCB Global Projects and Development
  • A track record of successful partnerships with both academia and leading drug discovery organizations; partnership is part of our philosophy.
  • Patients are at the heart of all we do, driving our commitment to the treatment of severe diseases
  • A focus on two therapeutic areas: neurology and immunology
  • An attractive late stage pipeline
  • An international R&D organization comprised of UCB New Medicines™ and UCB Global Projects and Development
  • A track record of successful partnerships with both academia and leading drug discovery organizations; partnership is part of our philosophy.

Our partnerships

To learn more about why partnerships matter to UCB, the different types of partnerships we like to establish and the partnering process, click here to visit the "Partnering" section of the website.